Kishor Bhatia

6PUBLICATIONS
46CO-AUTHORS
Molecular targetsGene and molecular therapyMedical parasitologyHost-parasite interactions
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Oct 08, 2026
Phase Ia Evaluation of LP-184 in Recurrent Glioblastoma: Safety, Pharmacokinetics, and Translational Optimization of CNS Exposure.

|Apr 17, 2024
LP-184, a Novel Acylfulvene Molecule, Exhibits Anticancer Activity against Diverse Solid Tumors with Homologous Recombination Deficiency.

Aditya Kulkarni, Jianli Zhou, Neha Biyani

|Aug 08, 2023
Conditional Dependency of LP-184 on Prostaglandin Reductase 1 is Synthetic Lethal in Pancreatic Cancers with DNA Damage Repair Deficiencies.

Diana Restifo, Joseph R McDermott, Dusica Cvetkovic

|Jul 26, 2023
Preclinical Efficacy of LP-184, a Tumor Site Activated Synthetic Lethal Therapeutic, in Glioblastoma.

Bachchu Lal, Aditya Kulkarni, Joseph McDermott

|Apr 30, 2021
Assessment of Mixed Plasmodium falciparum sera5 Infection in Endemic Burkitt Lymphoma: A Case-Control Study in Malawi.

Nobuko Arisue, George Chagaluka, Nirianne Marie Q Palacpac

|Mar 09, 2019
Genetic signatures of gene flow and malaria-driven natural selection in sub-Saharan populations of the "endemic Burkitt Lymphoma belt".

Mateus H Gouveia, Andrew W Bergen, Victor Borda

Pageof 1

Frequent Collaborators

3 joint publications

Umesh Kathad

3 joint publications

Jianli Zhou

3 joint publications

Aditya Kulkarni

2 joint publications

Hernando Lopez-Bertoni